Petrus Trust Company LTA Takes Position in USANA Health Sciences, Inc. $USNA

Key Points

• Petrus Trust Company LTA has acquired a new stake in USANA Health Sciences, purchasing 13,411 shares valued at approximately $362,000.
• USANA Health Sciences reported a net margin of 3.79% and earnings per share (EPS) of $0.74 for the last quarter, exceeding analyst expectations.
• Two analysts upgraded USANA's stock from a "hold" rating to a "buy" rating, while consensus remains a "hold" with an average price target of $36.00.

Petrus Trust Company LTA purchased a new stake in USANA Health Sciences, Inc. (NYSE:USNA - Free Report) in the 1st quarter, according to its most recent disclosure with the SEC. The fund purchased 13,411 shares of the company's stock, valued at approximately $362,000. Petrus Trust Company LTA owned 0.07% of USANA Health Sciences as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also modified their holdings of the company. Teacher Retirement System of Texas acquired a new position in shares of USANA Health Sciences in the 1st quarter valued at about $888,000. GAMMA Investing LLC boosted its holdings in shares of USANA Health Sciences by 49,082.4% in the 1st quarter. GAMMA Investing LLC now owns 8,361 shares of the company's stock valued at $225,000 after buying an additional 8,344 shares during the period. US Bancorp DE boosted its holdings in shares of USANA Health Sciences by 13.1% in the 1st quarter. US Bancorp DE now owns 4,611 shares of the company's stock valued at $124,000 after buying an additional 535 shares during the period. Millennium Management LLC acquired a new position in shares of USANA Health Sciences in the 4th quarter valued at about $633,000. Finally, Exchange Traded Concepts LLC boosted its holdings in shares of USANA Health Sciences by 7.1% in the 1st quarter. Exchange Traded Concepts LLC now owns 9,184 shares of the company's stock valued at $248,000 after buying an additional 606 shares during the period. 54.25% of the stock is owned by institutional investors and hedge funds.

USANA Health Sciences Price Performance

USANA Health Sciences stock opened at $31.78 on Monday. The firm has a 50 day simple moving average of $31.24 and a 200-day simple moving average of $29.57. The stock has a market capitalization of $580.58 million, a PE ratio of 17.65, a price-to-earnings-growth ratio of 1.01 and a beta of 0.64. USANA Health Sciences, Inc. has a 12-month low of $23.10 and a 12-month high of $41.83.

USANA Health Sciences (NYSE:USNA - Get Free Report) last released its earnings results on Tuesday, July 22nd. The company reported $0.74 EPS for the quarter, beating the consensus estimate of $0.54 by $0.20. USANA Health Sciences had a net margin of 3.79% and a return on equity of 9.48%. The business had revenue of $235.85 million during the quarter, compared to analyst estimates of $225.20 million. USANA Health Sciences has set its FY 2025 guidance at 2.350-3.000 EPS. On average, analysts forecast that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, Wall Street Zen raised shares of USANA Health Sciences from a "hold" rating to a "buy" rating in a research note on Thursday, May 22nd. Two analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $36.00.

Insider Activity at USANA Health Sciences

In related news, insider David Mulham Mulham sold 3,515 shares of the company's stock in a transaction that occurred on Wednesday, July 30th. The shares were sold at an average price of $30.26, for a total value of $106,363.90. Following the completion of the sale, the insider owned 9,260 shares in the company, valued at approximately $280,207.60. This represents a 27.51% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Gilbert A. Fuller sold 1,058 shares of the company's stock in a transaction that occurred on Thursday, August 7th. The shares were sold at an average price of $29.10, for a total transaction of $30,787.80. The disclosure for this sale can be found here. 0.63% of the stock is owned by corporate insiders.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.

Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.